Off-Label but On-Target: Sacral Neuromodulation for Neurogenic Bladder Dysfunction. [PDF]
Curr Urol RepVogel K, Nakib N.
europepmc +1 more source
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: A review [PDF]
, 2010 Jared Moreines +2 more
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Gait and balance impairment is a disabling clinical feature in people with degenerative cerebellar ataxia. Objectives We performed a rater‐blinded, parallel 3‐arm randomized controlled trial with delayed‐start‐design (exploratory proof‐of‐concept study) to assess whether, compared to control, people with mild/moderate hereditary ...
Clara Rentz +12 more
wiley +1 more source
Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled randomised trial. [PDF]
BMJ OpenSt-Pierre J +6 more
europepmc +1 more source
A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations
Movement Disorders Clinical Practice, EarlyView.Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier +12 more
wiley +1 more source
Effect of a Peripheral Neuromodulation Protocol Combined with the Application of Therapeutic Exercise in Patients Diagnosed with Urinary Incontinence-A Study Protocol for a Randomized Controlled Trial. [PDF]
Healthcare (Basel)Leal-García J +6 more
europepmc +1 more source
Interleukin‐6‐type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function [PDF]
, 2010 Shamsudheen Moidunny +6 more
openalex +1 more source